Common use of DESCRIPTION OF WARRANTS Clause in Contracts

DESCRIPTION OF WARRANTS. We may issue warrants to purchase our ordinary shares in one or more series together with other securities or separately, as described in the applicable prospectus supplement. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The warrant agent will act solely as our agent and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants. The terms of any warrants to be issued and a description of the material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplement. The applicable prospectus supplement will describe the following terms of any warrants in respect of which this prospectus is being delivered: • the title of such warrants; • the aggregate number of such warrants; • the price or prices at which such warrants will be issued; • the price at which, and the currency or currencies in which, the securities upon exercise of such warrants may be purchased; • the designation, amount and terms of the securities purchasable upon exercise of such warrants; • the date on which the right to exercise such warrants shall commence and the date on which such right shall expire; • if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; • if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; • if applicable, the date on and after which such warrants and the related securities will be separately transferable; • information with respect to book-entry procedures, if any; • if applicable, any material Israeli and U.S. federal income tax considerations; • the anti-dilution provisions of such warrants, if any; and • any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.

DESCRIPTION OF WARRANTS. We may issue warrants to for the purchase our ordinary shares in one of preferred stock, common stock, or more series any combination thereof. We may issue warrants independently or together with any other securities offered by any prospectus supplement and may be attached to or separately, as described in separate from the applicable prospectus supplementother offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between by us and with a warrant agent. The warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. The Further terms of any the warrants to be issued and a description of the material provisions of the applicable warrant agreement agreements will be set forth in the applicable prospectus supplement. The applicable prospectus supplement relating to any particular issue of warrants will describe the following terms of any warrants in respect of which this prospectus is being deliveredthe warrants, including, as applicable, the following: • · the title of such the warrants; • · the aggregate number of such the warrants; • · the price or prices at which such the warrants will be issued; • · the designation, terms and number of shares of preferred stock or common stock purchasable upon exercise of the warrants; · the designation and terms of the offered securities, if any, with which the warrants are issued and the number of the warrants issued with each offered security; · the date, if any, on and after which the warrants and the related preferred stock or common stock will be separately transferable; · the price at which, and the currency which each share of preferred stock or currencies in which, the securities common stock purchasable upon exercise of such the warrants may be purchased; • the designation, amount and terms of the securities purchasable upon exercise of such warrants; • · the date on which the right to exercise such the warrants shall commence and the date on which such that right shall expire; • if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; • if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; • if applicable, the date on and after which such warrants and the related securities will be separately transferable; • information with respect to book-entry procedures, if any; • if applicable, any material Israeli and U.S. federal income tax considerations; • the anti-dilution provisions of such warrants, if any; and • any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.;

DESCRIPTION OF WARRANTS. We may issue warrants to purchase shares of our ordinary shares common stock, preferred stock, or other securities, as applicable in one or more series together with other securities or separatelyseries, as described in the applicable prospectus supplement. Each series Below is a description of certain general terms and provisions of the warrants that we may offer. Particular terms of the warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The warrant agent will act solely as our agent and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants. The terms of any warrants to be issued and a description of the material provisions of described in the applicable warrant agreement will be set forth in agreements and the applicable prospectus supplementsupplement for the warrants. The To the extent appropriate, the applicable prospectus supplement will describe contain, where applicable, the following terms of any warrants in respect of which this prospectus is being deliveredand other information relating to the warrants: • the title of such specific designation and aggregate number of, and the price at which we will issue, the warrants; • the aggregate number of such warrants; • currency or currency units in which the price or prices at which such warrants will be issued; • the price at whichoffering price, if any, and the currency or currencies in which, the securities upon exercise of such warrants may be purchasedprice are payable; • the designation, amount and terms of the securities purchasable upon exercise of such the warrants; • if applicable, the exercise price for shares of our common stock, preferred stock, or other securities, as applicable, and the number of shares of common stock, preferred stock, or other securities, as applicable, to be received upon exercise of the warrants; • the date on which the right to exercise such the warrants shall commence will begin and the date on which such that right shall expirewill expire or, if the warrants may not be continuously exercised throughout that period, the specific date or dates on which the warrants may be exercised; • whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms; • any applicable material U.S. federal income tax consequences; • the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; • the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange; • if applicable, the date from and after which the warrants and the common stock, preferred stock, or other securities, as applicable, will be separately transferable; • if applicable, the minimum or maximum amount of such the warrants which that may be exercised at any one time; • if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; • if applicable, the date on and after which such warrants and the related securities will be separately transferable; • information with respect to book-entry procedures, if any; • if applicable, any material Israeli and U.S. federal income tax considerations; • the anti-dilution provisions of such the warrants, if any; and • any other redemption or call provisions; • any additional terms of such the warrants, including terms, procedures and limitations relating to the exchange and exercise of such the warrants.. 9

DESCRIPTION OF WARRANTS. We may issue warrants to purchase shares of our ordinary shares common stock or preferred stock in one or more series together with other securities or separately, as described in the each applicable prospectus supplement. Each series Below is a description of certain general terms and provisions of the warrants that we may offer. Particular terms of the warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The warrant agent will act solely as our agent and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants. The terms of any warrants to be issued and a description of the material provisions of described in the applicable warrant agreement will be set forth in agreements and the applicable prospectus supplementsupplement for the warrants. As of September 30, 2021, we had warrants outstanding that represent the right to acquire 39,474 shares of common stock. The applicable prospectus supplement will describe contain, where applicable, the following terms of any warrants in respect of which this prospectus is being deliveredand other information relating to the warrants: • the title of such specific designation and aggregate number of, and the price at which we will issue, the warrants; • the aggregate currency or currency units in which the offering price, if any, and the exercise price are payable; • if applicable, the exercise price for shares of our common stock and the number of such shares of common stock to be received upon exercise of the warrants; • if applicable, the exercise price or prices at which such warrants will for shares of our preferred stock, the number of shares of preferred stock to be issued; • the price at whichreceived upon exercise, and the currency a description of that class or currencies in which, the securities upon exercise series of such warrants may be purchased; • the designation, amount and terms of the securities purchasable upon exercise of such warrantsour preferred stock; • the date on which the right to exercise such the warrants shall commence will begin and the date on which such that right shall expirewill expire or, if the warrants may not be continuously exercised throughout that period, the specific date or dates on which the warrants may be exercised; • whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit; • any applicable material U.S. federal income tax consequences; • the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; • the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange; • if applicable, the date from and after which the warrants and the common stock and/or preferred stock will be separately transferable; • if applicable, the minimum or maximum amount of such the warrants which that may be exercised at any one time; • if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; • if applicable, the date on and after which such warrants and the related securities will be separately transferable; • information with respect to book-entry procedures, if any; • if applicable, any material Israeli and U.S. federal income tax considerations; • the anti-dilution provisions of such the warrants, if any; • any redemption or call provisions; • whether the warrants are to be sold separately or with other securities as parts of units; and • any other additional terms of such the warrants, including terms, procedures and limitations relating to the exchange and exercise of such the warrants. The transfer agent and registrar for any warrants will be set forth in the applicable prospectus supplement.

DESCRIPTION OF WARRANTS. We may issue warrants to purchase our ordinary shares, preferred shares, depositary shares in or debt securities. We may offer warrants separately or together with one or more series together with other additional warrants, ordinary shares, preferred shares, depositary shares or debt securities, or any combination of those securities or separatelyin the form of units, as described in the applicable prospectus supplement. Each series If we issue warrants as part of a unit, the accompanying prospectus supplement will specify whether those warrants will may be issued under a separate warrant agreement separated from the other securities in the unit prior to be entered into between us and a warrant agent. The warrant agent will act solely as our agent and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants. The terms of any warrants to be issued and a description the expiration date of the material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplementwarrants. The applicable prospectus supplement will also describe the following terms of any warrants in respect of which this prospectus is being deliveredwarrants: • the title of such specific designation and aggregate number of, and the offering price at which we will issue, the warrants; • the aggregate number of such warrants; • currency or currency units in which the price or prices at which such warrants will be issued; • the price at whichoffering price, if any, and the currency or currencies in which, the securities upon exercise of such warrants may be purchased; • the designation, amount and terms of the securities purchasable upon exercise of such warrantsprice are payable; • the date on which the right to exercise such the warrants shall commence will begin and the date on which such that right shall expirewill expire or, if you may not continuously exercise the warrants throughout that period, the specific date or dates on which you may exercise the warrants; • whether the warrants are to be sold separately or with other securities as parts of units; • whether the warrants will be issued in definitive or global form or in any combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit; • any applicable material U.S. federal income tax consequences; • the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; • the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange; • the designation and terms of any equity securities purchasable upon exercise of the warrants; • the designation, aggregate principal amount, currency and terms of any debt securities that may be purchased upon exercise of the warrants; • if applicable, the designation and terms of the preferred shares or depositary shares with which the warrants are issued and the number of warrants issued with each security; • if applicable, the date from and after which any warrants issued as part of a unit and the related debt securities, preferred shares, depositary shares or ordinary shares will be separately transferable; • the number of ordinary shares, preferred shares or depositary shares purchasable upon exercise of a warrant and the price at which those shares may be purchased; • if applicable, the minimum or maximum amount of such the warrants which that may be exercised at any one time; • if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; • if applicable, the date on and after which such warrants and the related securities will be separately transferable; • information with respect to book-entry procedures, if any; • if applicable, any material Israeli and U.S. federal income tax considerations; • the anti-dilution provisions of such of, and other provisions for changes to or adjustment in the exercise price of, the warrants, if any; • any redemption or call provisions; and • any other additional terms of such the warrants, including terms, procedures and limitations relating to the exchange and or exercise of such the warrants.